STOCK TITAN

Versus Systems Inc. 10-Q Filings

VS NASDAQ

Every 10-Q that Versus Systems Inc. (VS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow VS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VS filings page.

Rhea-AI Summary

Versus Systems Inc., a fan engagement and rewards technology company, reported Q2 2026 revenue of $1.49M, almost entirely from a related-party license with ASPIS, and generated operating income of $0.6M with net income attributable to shareholders of $0.47M ($0.10 per share). For the first six months of 2026, revenue was $1.51M and the company posted a small net loss of $0.22M.

Cash and cash equivalents increased to $1.36M at June 30, 2026, helped by a $1.7M common stock sale to ASPIS, which also renewed a functional technology license generating $1.49M of recognized revenue in the quarter. Stockholders’ equity rose to $3.55M, and Versus disclosed that ASPIS beneficially owned about 55.79% of its common shares, with an affiliate holding another 15.94%. Management nonetheless stated there is substantial doubt about the company’s ability to continue as a going concern absent additional funding, given limited cash and continued losses. The company also reported Nasdaq had previously flagged a stockholders’ equity deficiency but later notified Versus it had regained compliance, and it acknowledged ongoing material weaknesses in internal control over financial reporting tied to cash disbursement and segregation-of-duties issues.

Rhea-AI Summary

Versus Systems (Nasdaq: VS) filed its Q3 2025 report showing lower year‑to‑date losses but ongoing liquidity pressure. The company posted a Q3 net loss of $757,997 with no revenue in the quarter. Year‑to‑date, revenue reached $2,179,348, driven largely by recognizing $1,980,000 from a functional license delivered to related party ASPIS in Q2.

Cash was $1,405,628 and working capital was $2,770,192 as of September 30, 2025. Management disclosed that recurring losses and limited operating cash flow raise substantial doubt about the company’s ability to continue as a going concern. Versus is pursuing financing and strategic options while emphasizing cost discipline and partnerships, including efforts to expand in Brazil. Shares outstanding were 4,901,677 as of November 12, 2025.